Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedOct 04, 2025
DataAggregated Company Financials
Companies11
  • 7D0.6%
  • 3M14.6%
  • 1Y91.6%
  • YTDn/a

The Pharma industry has stayed flat over the last week. The past year has been better, since the industry has gained 90% in that time. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 04 Oct 2025PK₨550.6bPK₨287.3bPK₨29.1b23x18.9x1.9x
Mon, 01 Sep 2025PK₨514.6bPK₨285.8bPK₨28.8b24.1x17.9x1.8x
Wed, 30 Jul 2025PK₨492.5bPK₨279.5bPK₨26.2b22.5x18.8x1.8x
Fri, 27 Jun 2025PK₨452.5bPK₨279.5bPK₨26.2b21.6x17.2x1.6x
Sun, 25 May 2025PK₨451.8bPK₨279.5bPK₨26.2b18.3x17.2x1.6x
Tue, 22 Apr 2025PK₨490.5bPK₨272.6bPK₨23.2b22.3x21.1x1.8x
Thu, 20 Mar 2025PK₨477.5bPK₨266.0bPK₨20.9b25.5x22.9x1.8x
Sat, 15 Feb 2025PK₨488.7bPK₨257.1bPK₨19.2b24.4x25.5x1.9x
Mon, 13 Jan 2025PK₨448.1bPK₨257.1bPK₨19.2b22.3x23.4x1.7x
Wed, 11 Dec 2024PK₨466.5bPK₨257.0bPK₨19.0b22.9x24.5x1.8x
Fri, 08 Nov 2024PK₨356.9bPK₨256.6bPK₨19.0b19.5x18.8x1.4x
Sun, 06 Oct 2024PK₨277.7bPK₨251.2bPK₨12.3b17.1x22.5x1.1x
Tue, 03 Sep 2024PK₨258.0bPK₨252.2bPK₨12.2b16.1x21.2x1x
Thu, 01 Aug 2024PK₨242.0bPK₨243.6bPK₨8.3b17x29.3x1x
Sat, 29 Jun 2024PK₨244.6bPK₨243.6bPK₨8.3b16.4x29.6x1x
Mon, 27 May 2024PK₨225.6bPK₨237.0bPK₨7.6b21.1x29.5x1x
Wed, 24 Apr 2024PK₨189.7bPK₨228.8bPK₨6.6b37.4x28.9x0.8x
Fri, 22 Mar 2024PK₨167.1bPK₨224.1bPK₨6.3b20.8x26.4x0.7x
Sun, 18 Feb 2024PK₨156.2bPK₨221.2bPK₨6.3b19.3x24.8x0.7x
Tue, 16 Jan 2024PK₨166.5bPK₨221.2bPK₨6.3b20.3x26.5x0.8x
Thu, 14 Dec 2023PK₨175.4bPK₨221.2bPK₨6.3b22.2x27.9x0.8x
Sat, 11 Nov 2023PK₨147.9bPK₨218.2bPK₨6.2b19.8x23.9x0.7x
Mon, 09 Oct 2023PK₨126.9bPK₨211.7bPK₨6.6b16x19.2x0.6x
Wed, 06 Sep 2023PK₨122.1bPK₨209.3bPK₨8.2b11.8x14.9x0.6x
Fri, 04 Aug 2023PK₨146.0bPK₨205.6bPK₨8.7b13.4x16.7x0.7x
Sun, 02 Jul 2023PK₨127.2bPK₨205.6bPK₨8.7b12.2x14.6x0.6x
Tue, 30 May 2023PK₨134.8bPK₨203.2bPK₨11.0b13x12.3x0.7x
Thu, 27 Apr 2023PK₨137.3bPK₨194.2bPK₨13.8b9.4x9.9x0.7x
Sat, 25 Mar 2023PK₨140.7bPK₨191.5bPK₨15.1b9.4x9.3x0.7x
Mon, 20 Feb 2023PK₨145.3bPK₨189.4bPK₨15.2b9.4x9.5x0.8x
Wed, 18 Jan 2023PK₨141.4bPK₨189.4bPK₨15.2b9.1x9.3x0.7x
Fri, 16 Dec 2022PK₨168.3bPK₨189.4bPK₨15.2b10.8x11x0.9x
Sun, 13 Nov 2022PK₨191.3bPK₨187.5bPK₨14.9b12.6x12.8x1x
Tue, 11 Oct 2022PK₨197.4bPK₨180.8bPK₨17.2b12x11.5x1.1x
Price to Earnings Ratio

11.5x


Total Market Cap: PK₨197.4bTotal Earnings: PK₨17.2bTotal Revenue: PK₨180.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 19.7x202320242025
Current Industry PE
  • Investors are relatively neutral on the Pakistani Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 19.7x.
  • The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 19% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Pakistani Pharma compare with similar industries?

PK Market2.98%
Healthcare0.34%
Pharma0.61%
Pharma0.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABOT Abbott Laboratories (Pakistan)PK₨1.30k2.2%
+PK₨2.7b
70.9%PE19.2x
SEARL SearlePK₨119.862.6%
+PK₨1.6b
113.7%PE31x
HINOON Highnoon LaboratoriesPK₨1.16k1.2%
+PK₨717.4m
66.5%PE17.5x
CPHL Citi PharmaPK₨99.291.8%
+PK₨393.0m
167.6%PE27.3x
FEROZ Ferozsons LaboratoriesPK₨410.412.0%
+PK₨356.0m
39.5%PE23x

Latest News